Thyroid dysfunctions secondary to cancer immunotherapy
ConclusionsCancer patients treated with monoclonal antibodies that block immune checkpoint inhibitors are at risk of developing thyroid dysfunctions. Their thyroid status should be assessed at baseline and periodically after initiation of the immunotherapy.
Source: Journal of Endocrinological Investigation - Category: Endocrinology Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Chemotherapy | Endocrinology | Immunotherapy | Thyroid | Thyroid Cancer | Vaccines